← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vivid Technologies
Houston, TX
$1,720,517
Total funding
8
Grants
Funding over time
peak $298K · FY2007–21$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,720,517 · 8
By mechanism
R43$1,720,517 · 8
Investigators at Vivid Technologies
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
In situ assay for topoisomerase 2-mediated DNA damage$236,684
R43 · FY2021 · GM
New specific and rapid assay for in situ apoptosis labeling for cancer studies$214,214
R43 · FY2020 · CA
Fluorescent Molecular Oscillator for DNA Damage Detection$199,395
R43 · FY2007 · RR
PEI-somes and cationization of protein probes for microimaging of nervous system$188,606
R43 · FY2009 · NS
PEI-somes and cationization of protein probes for microimaging of nervous system$173,170
R43 · FY2010 · NS
Fluorescent Molecular Oscillator for DNA Damage Detection$163,229
R43 · FY2008 · RR
In situ assay for RNA decapping in tumors$149,051
R43 · FY2018 · CA
MV-ligase probes for visualization of apoptotic clearance$149,051
R43 · FY2013 · GM
In situ assay for DNA cleavage by topoisomerase II$148,463
R43 · FY2011 · GM
Assay for detection of early stage apoptosis$98,654
R43 · FY2007 · GM